Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by InTrack Investment Management Inc

InTrack Investment Management Inc lowered its position in Simulations Plus, Inc. (NASDAQ:SLPFree Report) by 3.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 31,335 shares of the technology company’s stock after selling 1,010 shares during the quarter. InTrack Investment Management Inc’s holdings in Simulations Plus were worth $1,289,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in SLP. Allspring Global Investments Holdings LLC purchased a new stake in Simulations Plus during the first quarter worth approximately $70,000. Tributary Capital Management LLC boosted its position in Simulations Plus by 2.1% during the 1st quarter. Tributary Capital Management LLC now owns 209,677 shares of the technology company’s stock worth $8,628,000 after purchasing an additional 4,310 shares during the period. Chatham Capital Group Inc. increased its holdings in Simulations Plus by 11.6% in the 1st quarter. Chatham Capital Group Inc. now owns 34,104 shares of the technology company’s stock valued at $1,403,000 after purchasing an additional 3,555 shares in the last quarter. Hennion & Walsh Asset Management Inc. raised its position in Simulations Plus by 49.0% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 35,845 shares of the technology company’s stock valued at $1,475,000 after purchasing an additional 11,794 shares during the period. Finally, Congress Asset Management Co. MA lifted its stake in shares of Simulations Plus by 34.6% during the first quarter. Congress Asset Management Co. MA now owns 171,490 shares of the technology company’s stock worth $7,057,000 after purchasing an additional 44,129 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Wall Street Analysts Forecast Growth

SLP has been the subject of a number of recent research reports. Oppenheimer increased their target price on Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Thursday, June 13th. Craig Hallum increased their price objective on shares of Simulations Plus from $51.00 to $56.00 and gave the company a “buy” rating in a research report on Thursday, June 13th. Finally, William Blair assumed coverage on shares of Simulations Plus in a research report on Friday. They set an “outperform” rating on the stock.

Read Our Latest Research Report on SLP

Insiders Place Their Bets

In other news, Director Daniel L. Weiner sold 3,250 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the transaction, the director now owns 8,759 shares of the company’s stock, valued at $423,147.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Simulations Plus news, Director Daniel L. Weiner sold 750 shares of the business’s stock in a transaction on Friday, June 28th. The shares were sold at an average price of $49.32, for a total transaction of $36,990.00. Following the completion of the sale, the director now owns 7,009 shares in the company, valued at $345,683.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel L. Weiner sold 3,250 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $48.31, for a total transaction of $157,007.50. Following the completion of the transaction, the director now owns 8,759 shares in the company, valued at $423,147.29. The disclosure for this sale can be found here. Insiders sold a total of 44,500 shares of company stock valued at $2,072,198 in the last ninety days. Corporate insiders own 20.90% of the company’s stock.

Simulations Plus Stock Performance

Shares of NASDAQ SLP traded up $0.68 during midday trading on Tuesday, reaching $46.86. 274,050 shares of the company’s stock were exchanged, compared to its average volume of 102,895. Simulations Plus, Inc. has a 52-week low of $32.69 and a 52-week high of $52.69. The business’s fifty day moving average price is $47.81 and its two-hundred day moving average price is $44.18. The stock has a market capitalization of $936.73 million, a PE ratio of 88.42 and a beta of 0.72.

Simulations Plus (NASDAQ:SLPGet Free Report) last posted its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.02. The company had revenue of $18.31 million for the quarter, compared to the consensus estimate of $17.31 million. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. Simulations Plus’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.20 EPS. Analysts predict that Simulations Plus, Inc. will post 0.55 earnings per share for the current fiscal year.

Simulations Plus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, May 6th. Shareholders of record on Monday, April 29th were paid a dividend of $0.06 per share. The ex-dividend date was Friday, April 26th. This represents a $0.24 dividend on an annualized basis and a yield of 0.51%. Simulations Plus’s dividend payout ratio (DPR) is 45.28%.

Simulations Plus Company Profile

(Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

See Also

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLPFree Report).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.